Sign in Subscribe
Scientists

E2F1 Mediates DNA Damage and Apoptosis through HCF-1 and MLL Family of Histone Methyltransferases

Strategic Insights

— 1 min read

Researchers at the University of Lausanne, Center for Integrative Genomics, have made a significant discovery in the field of apoptosis, shedding new light on the molecular mechanisms that drive DNA damage and cell death. According to the study, E2F1, a key regulator of human cell proliferation, plays a critical role in modulating the cell cycle and inducing apoptosis in cancer cells. The team, led by S. Tyagi, demonstrated that the association of E2F1 with HCF-1 and the MLL family of histone H3 lysine 4 (H3K4) methyltransferases is essential for E2F1 to stimulate both DNA damage and apoptosis.

Key Takeaways:

  • E2F1 is a key positive regulator of human cell proliferation, and its activity is altered in essentially all human cancers.
  • Deregulation of E2F1 leads to oncogenic DNA damage and anti-oncogenic apoptosis, highlighting its dual role in cancer progression.
  • The molecular mechanisms by which E2F1 mediates DNA damage and apoptosis are poorly understood, but are crucial for understanding cancer progression and development of targeted therapies.
  • The E2F1 HCF-1-binding sequence permits E2F1 to stimulate both DNA damage and apoptosis, and HCF-1 and the MLL family of H3K4 methyltransferases have essential functions in these processes.
  • Sequence changes in the E2F1 HCF-1-binding site can modulate both up and down the ability of E2F1 to induce apoptosis, indicating that HCF-1 association with E2F1 is a regulator of E2F1-induced apoptosis.
  • The discovery has significant implications for our understanding of cancer biology and the development of novel therapeutic strategies targeting specific molecular mechanisms.
  • Researchers at the University of Lausanne, led by S. Tyagi, have made a groundbreaking contribution to the field of apoptosis research, paving the way for further studies on the molecular mechanisms underlying E2F1-mediated apoptosis.

Statistics:

  • The study was published in The EMBO Journal in 2009 (Volume 28, Issue 20, pp. 3185-3195).
  • E2F1 is altered in essentially all human cancers, highlighting its critical role in cancer progression.
  • The association of E2F1 with HCF-1 and the MLL family of H3K4 methyltransferases is essential for E2F1 to stimulate both DNA damage and apoptosis.

Sources:

  • Tyagi, S., et al. "E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases." The EMBO Journal, vol. 28, no. 20, 2009, pp. 3185-3195.
  • University of Lausanne, Center for Integrative Genomics, Genopode, Lausanne, Switzerland.
  • The EMBO Journal, Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA.

Read more